期刊文献+

MEK/ERK信号通路在RANKL诱导的乳腺癌MCF-7细胞迁移中的作用及机制探讨

The Role of MEK/ERK pathway in RANKL-induced breast cancer cell MCF-7 migration
下载PDF
导出
摘要 目的探讨细胞外调节蛋白激酶(ERK)信号通路在核因子-κB受体活化因子配体(RANKL)诱导的乳腺癌细胞MCF-7迁移中的作用。方法流式细胞术检测MCF-7细胞表面核因子-κB受体活化因子(RANK)蛋白的表达;Western blot检测RANKL刺激后磷酸化ERK(p-ERK)及ERK的表达;Transwell法测定RANKL刺激后细胞迁移能力的改变。结果 MCF-7细胞表面表达RANK蛋白,RANKL(2μg/mL)显著诱导MCF-7细胞迁移能力增强。RANKL刺激后MCF-7细胞p-ERK表达逐渐升高,MEK抑制剂PD98059显著抑制RANKL诱导的MCF-7细胞迁移。结论 ERK信号通路参与RANKL诱导的乳腺癌细胞MCF-7迁移。 Objective To explore the role of extracellular signal-regulated kinase in receptor activator for nuclear factor kappaB ligand(RANKL) induced breast cancer cells migration.Methods Receptor activator for nuclear factor kappaB(RANK) protein expression on the surface of breast cacner MCF-7 cell was detected by fluorescence-activated cell sorting(FACS).Western blot assayed the expression of phospho-ERK and ERK.Transwell assayed the migration of MCF-7 cells.Results Fluorescence-activated cell sorting showed that RANK was expressed in human breast cancer cell line MCF-7,and RANKL significantly promoted the migration of MCF-7 cells.The expression of phospho-ERK increased from 5 to 30 minutes after RANKL stimulation.PD98059,the MEK inhibitor obviously blocked RANKL-induced MCF-7 cells migration.Conclusion ERK pathway was involved in RANKL induced breast cancer cell MCF-7 migration.
出处 《山东医药》 CAS 2012年第4期44-45,48,I0003,共4页 Shandong Medical Journal
基金 国家青年科学基金资助项目(30700807) 辽宁省教育厅重点实验室项目(2008S246)
关键词 乳腺肿瘤 细胞外信号调节蛋白激酶 核因子-ΚB受体活化因子配体 细胞运动 breast neoplasms extracellular signal-regulated kinase receptor activator for nuclear factor kappaB ligand cell movement
  • 相关文献

参考文献1

二级参考文献7

  • 1Seger R, Krebs EG. The MAPK signaling cascade[J]. FASEBJ, 1995, 9: 726-735.
  • 2Piwien-Pilipuk G, Huo JS, Schwartz J. Growth hormone signal transduction[J]. J Pediatr Endocrinol Metab, 2002, 15: 771-786.
  • 3Weinstein-Oppenheimer CR, Blalock WL, Steelman LS, et al. The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors[J]. Pharmacol Ther, 2000, 88: 229-279.
  • 4Cowly S, Paterson H, Kemp P, et al. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells[J]. Cell, 1994, 77: 841-852.
  • 5Salh B, Marotta A, Matthewson C, et al. Investigation of Mek-MAP kinase-RSK pathway in human breast cancer[J]. Anticancer Res, 1999, 19: 731-740.
  • 6Fiddes RJ, Janes PW, Sivertsen SP, et al. Inhibition of the MAP kinase cascade blocks heregulin induced cell cycle progression in T47D human breast cancer cell[J]. Oncogene, 1998, 16: 2803-2813.
  • 7Das R, Vonderhaar BK. Activation of raf1, MEK, and MAP kinase in prolactin responsive mammary cells[J]. Breast Cancer Res, 1996, 40: 141-149.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部